Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin
2006 ◽
Vol 309
(1-2)
◽
pp. 81-86
◽
2018 ◽
Vol 15
(11)
◽
pp. 5124-5134
◽
2013 ◽
Vol 41
(1)
◽
pp. 170-176
◽
2006 ◽
Vol 95
(9)
◽
pp. 1984-1993
◽
2002 ◽
Vol 20
(7)
◽
pp. 1951-1952
◽
2012 ◽
Vol 132
(10)
◽
pp. 2439-2447
◽
1997 ◽
Vol 94
(5)
◽
pp. 2031-2035
◽
2019 ◽
Vol 25
(2)
◽
pp. 178-186
◽
Keyword(s):
2013 ◽
Vol 111
◽
pp. 346-353
◽
2019 ◽
Vol 16
(9)
◽
pp. 3842-3852
◽